Patient information: uses, side effects, how to take - Dopamine
INSTRUCTIONS FOR USE
To Open
Tear outer wrap at notch and remove solution container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
Preparation for Administration
(Use aseptic technique)
1.
Close flow control clamp of administration set.
2.
Remove cover from outlet port at bottom of container.
3.
Insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. NOTE: See full directions on administration set carton.
4.
Suspend container from hanger.
5.
Squeeze and release drip chamber to establish proper fluid level in chamber.
6.
Open flow control clamp and clear air from set. Close clamp.
7.
Attach set to venipuncture device. If device is not indwelling, prime and make venipuncture.
8.
Regulate rate of administration with an infusion pump, preferably a volumetric pump.
WARNING: Do not use flexible container in series connections.
About this document
Source: FDA drug labeling via NLM DailyMed · Application number: NDA 018826
· View the label on DailyMed
Revision date stated in the text: March 2018
Found a mistake? Write to us via the contact page.
The information on this site does not replace the advice of a doctor or pharmacist.
Drug information for Dopamine
| Rx or OTC |
Prescription (Rx)?
- This drug is available only with a prescription from a licensed healthcare provider.
- Rx
|
| Drug class |
Catecholamine |
| Active ingredient |
Dopamine hydrochloride 1.6 mg/mL
|
| Dosage form |
Injection, solution |
| Route |
Intravenous |
| Marketing status |
listed in the FDA NDC Directory |
| Company (applicant) |
HOSPIRA |
| FDA approval |
NDA 018826New Drug Application (NDA)
Approved September 30, 1983
|
| Reference listed drug |
This is the reference listed drug (RLD) that generics are compared with. |
| Therapeutic equivalence (TE) code |
APCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book). |
| Manufacturers |
3 labelers list this drug on DailyMed |
| Drug shortage |
-
Current since November 3, 2026
|
| Recalls |
-
September 4, 2026: Class II recall: Lack of Assurance of Sterility
|
| Packages (NDC) |
| Package |
|
1.6 mg/mL – 250 ml in 1 bag
NDC 51662-1316-1
|
|
1.6 mg/mL – 250 ml in 1 bag / 1 in 1 pouch / 12 in 1 case
NDC 51662-1316-2
|
|
Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.
